{"id": "1369193856474972161", "creation": 1615276228.0, "user_id": "1195310926976765952", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 5, "quote_count": 0}}, "text": "New in @TheLancetInfDis&gt; Safety and immunogenicity of an inactivated #SARSCoV2 #vaccine, #BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial https://t.co/C1VIYGPCO6 #COVID19", "first_save": 1634559108.199414, "hashtags": ["#SARSCOV2", "#VACCINE", "#BBV152", "#COVID19"]}